Iikuni40 and co-workers prepared 111In and a 90Y-labeled ureidosulfonamide scaffold (US) to target carbonic anhydrase-IX (CA-IX), which is a typical biomarker highly expressed in many hypoxic tumor cells. This evidence concerns the gene CA9 and neoplasm.